WHO expert group fails to find a definitive answer for how COVID-19 began
LONDON (AP) — An expert group charged by the World Health Organization to investigate how the COVID-19 pandemic started released its final report Friday, reaching an unsatisfying conclusion: Scientists still aren't sure how the worst health emergency in a century began.
At a press briefing on Friday, Marietjie Venter, the group's chair, said that most scientific data supports the hypothesis that the new coronavirus jumped to humans from animals.
That was also the conclusion drawn by the first WHO expert group that investigated the pandemic's origins in 2021, when scientists concluded the virus likely spread from bats to humans, via another intermediary animal. At the time, WHO said a lab leak was 'extremely unlikely.'
Venter said that after more than three years of work, WHO's expert group was unable to get the necessary data to evaluate whether or not COVID-19 was the result of a lab accident, despite repeated requests for hundreds of genetic sequences and more detailed biosecurity information that were made to the Chinese government.
'Therefore, this hypothesis could not be investigated or excluded,' she said. 'It was deemed to be very speculative, based on political opinions and not backed up by science.' She said that the 27-member group did not reach a consensus; one member resigned earlier this week and three others asked for their names to be removed from the report.
Venter said there was no evidence to prove that COVID-19 had been manipulated in a lab, nor was there any indication that the virus had been spreading before December 2019 anywhere outside of China.
'Until more scientific data becomes available, the origins of how SARS-CoV-2 entered human populations will remain inconclusive,' Venter said, referring to the scientific name for the COVID-19 virus.
WHO Director-General Tedros Adhanom Ghebreyesus said it was a 'moral imperative' to determine how COVID began, noting that the virus killed at least 20 million people, wiped at least $10 trillion from the global economy and upended the lives of billions.
Last year, the AP found that the Chinese government froze meaningful domestic and international efforts to trace the virus' origins in the first weeks of the outbreak in 2020 and that WHO itself may have missed early opportunities to investigate how COVID-19 began.
U.S. President Donald Trump has long blamed the emergence of the coronavirus on a laboratory accident in China, while a U.S. intelligence analysis found there was insufficient evidence to prove the theory.
Chinese officials have repeatedly dismissed the idea that the pandemic could have started in a lab, saying that the search for its origins should be conducted in other countries.
Last September, researchers zeroed in on a short list of animals they think might have spread COVID-19 to humans, including racoon dogs, civet cats and bamboo rats.
__
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hamilton Spectator
an hour ago
- Hamilton Spectator
Death toll rises to 36 after explosion at a pharmaceutical factory in southern India
HYDERABAD, India (AP) — The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India's southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday. The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state's fire services director G.V. Narayana Rao told The Associated Press. Two other workers succumbed to burns and were pronounced dead in hospital, Rao said, adding that debris of the gutted pharmaceutical unit of Sigachi Industries was still being removed to find out if any more workers were trapped. Nearly three dozen injured workers were admitted to hospitals, he said. 'The whole structure of the factory has collapsed. Fire has been doused, and we hope to finish removing the debris in the next few hours,' Rao said. The explosion and subsequent fire was reported on Monday in the factory's spray dryer unit, which is used to process raw material into fine powder for making drugs, Rao said. The state's Health Minister Damodar Raja Narasimha said there were 108 workers inside the factory at the time of the explosion. 'As bodies were badly burnt and mutilated, a special medical team has been deployed to conduct DNA tests', said Narasimha, adding the state government has set up a panel to investigate the cause of the incident. Witnesses said they heard the explosion from a couple of kilometers away from the site. India is home to some of the world's top pharmaceutical companies, playing a pivotal role in the global supply of generic medicines and vaccines. The country's robust manufacturing and cost-effective production have made it a hub for pharma giants. Industrial accidents, particularly involving chemical reactors, aren't uncommon in such factories, underlining the need for authorities to implement stringent safety protocols and regulatory oversight in a sector critical to public health. Sigachi Industries Limited is an Indian company dealing with active pharmaceutical ingredients, intermediates and vitamin-mineral blends, according to the company's website. It has five manufacturing facilities across India and subsidiaries in the U.S and the United Arab Emirates. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .


The Hill
an hour ago
- The Hill
Death toll rises to 36 after explosion at a pharmaceutical factory in southern India
HYDERABAD, India (AP) — The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India's southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday. The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state's fire services director G.V. Narayana Rao told The Associated Press. Two other workers succumbed to burns and were pronounced dead in hospital, Rao said, adding that debris of the gutted pharmaceutical unit of Sigachi Industries was still being removed to find out if any more workers were trapped. Nearly three dozen injured workers were admitted to hospitals, he said. 'The whole structure of the factory has collapsed. Fire has been doused, and we hope to finish removing the debris in the next few hours,' Rao said. The explosion and subsequent fire was reported on Monday in the factory's spray dryer unit, which is used to process raw material into fine powder for making drugs, Rao said. The state's Health Minister Damodar Raja Narasimha said there were 108 workers inside the factory at the time of the explosion. 'As bodies were badly burnt and mutilated, a special medical team has been deployed to conduct DNA tests', said Narasimha, adding the state government has set up a panel to investigate the cause of the incident. Witnesses said they heard the explosion from a couple of kilometers away from the site. India is home to some of the world's top pharmaceutical companies, playing a pivotal role in the global supply of generic medicines and vaccines. The country's robust manufacturing and cost-effective production have made it a hub for pharma giants. Industrial accidents, particularly involving chemical reactors, aren't uncommon in such factories, underlining the need for authorities to implement stringent safety protocols and regulatory oversight in a sector critical to public health. Sigachi Industries Limited is an Indian company dealing with active pharmaceutical ingredients, intermediates and vitamin-mineral blends, according to the company's website. It has five manufacturing facilities across India and subsidiaries in the U.S and the United Arab Emirates.


San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Death toll rises to 36 following an explosion and fire at a southern India pharmaceutical factory
HYDERABAD, India (AP) — The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India's southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday. The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state's fire services director G.V. Narayana Rao told The Associated Press. Two other workers succumbed to burns and were pronounced dead in hospital, Rao said, adding that debris of the gutted pharmaceutical unit of Sigachi Industries was still being removed to find out if any more workers were trapped. Nearly three dozen injured workers were admitted to hospitals, he said. 'The whole structure of the factory has collapsed. Fire has been doused, and we hope to finish removing the debris in the next few hours,' Rao said. The explosion and subsequent fire was reported on Monday in the factory's spray dryer unit, which is used to process raw material into fine powder for making drugs, Rao said. The state's Health Minister Damodar Raja Narasimha said there were 108 workers inside the factory at the time of the explosion. 'As bodies were badly burnt and mutilated, a special medical team has been deployed to conduct DNA tests', said Narasimha, adding the state government has set up a panel to investigate the cause of the incident. Witnesses said they heard the explosion from a couple of kilometers away from the site. India is home to some of the world's top pharmaceutical companies, playing a pivotal role in the global supply of generic medicines and vaccines. The country's robust manufacturing and cost-effective production have made it a hub for pharma giants. Industrial accidents, particularly involving chemical reactors, aren't uncommon in such factories, underlining the need for authorities to implement stringent safety protocols and regulatory oversight in a sector critical to public health. Sigachi Industries Limited is an Indian company dealing with active pharmaceutical ingredients, intermediates and vitamin-mineral blends, according to the company's website. It has five manufacturing facilities across India and subsidiaries in the U.S and the United Arab Emirates.